DAFNA Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

DAFNA Capital Management’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,593	Closed	-$170K	–	94
2022 Q2	$170K	Buy	8,593 +2,500	+41%	+$55.5K	0.05%	88
2022 Q1	$219K	Sell	6,093 -12,220	-67%	-$454K	0.06%	89
2021 Q4	$820K	Hold	18,313	–	–	0.21%	69
2021 Q3	$1.3M	Buy	18,313 +1,375	+8%	+$156K	0.35%	63
2021 Q2	$2.24M	Hold	16,938	–	–	0.47%	46
2021 Q1	$2.27M	Buy	+16,938	New	+$2.15M	0.54%	44
2020 Q4	–	Sell	-2,152	Closed	-$164K	–	85
2020 Q3	$164K	Hold	2,152	–	–	0.05%	78
2020 Q2	$172K	Hold	2,152	–	–	0.05%	85
2020 Q1	$88K	Sell	2,152 -790	-27%	-$60K	0.04%	78
2019 Q4	$239K	Buy	+2,942	New	+$210K	0.08%	78

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DAFNA Capital Management's ASLN Position: Q3 2022 in Review

DAFNA Capital Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2022, closing a stake of 8,593 shares — an estimated $170K sold.

DAFNA Capital Management first reported a position in ASLN in Q4 2019 and held it in 10 quarters. The position peaked at $2.27M in Q1 2021. 27 funds tracked by Wall St. Rank hold ASLN as of Q3 2022.

DAFNA Capital Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2022 after selling out during the quarter.
DAFNA Capital Management sold 8,593 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2022, an estimated $170K.
DAFNA Capital Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 10 quarters.
DAFNA Capital Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $2.27M in Q1 2021.
27 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2022.

Based on DAFNA Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.